RSV/hMPV vaccine trial
A trial evaluating the potential of a new vaccine technology for prevention of 2 respiratory viruses in participants of good general health aged between 60 to 83 years.
Participants will attend 9 scheduled clinic visits at South Bank and 5 scheduled phone calls over approximately 2 years and will be paid up to $2,125 upon completion of the trial.
Vaccine patch trial
A trial evaluating a needle-free avian influenza vaccine patch for pandemic response in participants of generally good health aged between 18 and 50 years (inclusive).
Participants will attend 12 visits at South Bank and 3 scheduled phone calls over approximately 13 months and will be paid will be paid $1560 on completion of the trial.
Apply for the vaccine patch trial
Please note that The University of Queensland is not conducting the clinical trials above. The trials are being conducted by USC Clinical Trials on behalf of ViceBio and Vaxxas.
